Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer
| Status: | Recruiting |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 99 |
| Updated: | 4/21/2016 |
| Start Date: | August 2009 |
| End Date: | December 2016 |
| Contact: | Jennifer Joiner |
| Email: | Jennifer.joiner@palomarhealth.org |
| Phone: | 760-739-3185 |
Phase 1 Study of Stereotactic Hypofractionated Radiosurgery of Low Grade Prostate Cancer/Early Stage
The purpose of this trial is to evaluate a short course of very focused (stereotactic)
external beam radiation therapy for the treatment of early stage prostate cancer.
The investigators will gather scientific information about the tolerance and side effects
this type of radiation. The investigators will then compare these results with those of
standard 8 week course of external beam radiation therapy to see if this study treatment is
equally or more effective in treating prostate cancer.
external beam radiation therapy for the treatment of early stage prostate cancer.
The investigators will gather scientific information about the tolerance and side effects
this type of radiation. The investigators will then compare these results with those of
standard 8 week course of external beam radiation therapy to see if this study treatment is
equally or more effective in treating prostate cancer.
Inclusion Criteria:
- Histologically confirmed adenocarcinoma of the prostate
- Gleason score ≤ 6 and low volume Gleason 7 (3+4)
- PSA < 10
- Clinical Stage of T2a or less
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- Prior radiation treatment for prostate cancer
- Gleason score > 7
- PSA > 10
- Clinical Stage of T2b or greater
We found this trial at
1
site
Click here to add this to my saved trials
